Audax Private Equity and Linden Capital Partners-backed StatLab Medical Products completed the acquisition of CellPath.

Audax Private Equity and Linden Capital Partners-backed StatLab Medical Products, a developer and manufacturer of medical diagnostic supplies and equipment, completed the acquisition of CellPath, a UK-based manufacturer and supplier of products and services focused on the histology and cytology markets. Financial terms were not disclosed. "We have long respected CellPath for their well-earned reputation of delivering innovative products that solve problems for labs, and are proud to welcome them to the StatLab family of brands. Now paired with the strategic acquisition of UK-based equipment manufacturer Pyramid Innovation in 2021, CellPath’s established European market position and complementary portfolio will empower meaningful international growth in the histology sector,” Mike Karsonovich, StatLab CEO.